Bodenstedt Matthias

Chief Financial Officer

Bodenstedt Matthias has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.

On the most recent filing, Bodenstedt Matthias is listed as Chief Financial Officer at MoonLake Immunotherapeutics. Inside the rolling window, Bodenstedt Matthias reported 1 open-market purchase totaling $99K in MLTX and 7 open-market sales totaling $3.2M in MLTX. The largest disclosed transaction in the window is a sale of 85,870 MLTX shares on Apr 9, 2026, worth $1.6M.

Companies traded

Other insiders at MLTX

Insider Buying

$99K

reported purchases (SEC code P)

Insider Selling

$3.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MLTXSale$862KJun 23SEC ↗
MLTXSale$297KJun 18SEC ↗
MLTXSale$55KJun 18SEC ↗
MLTXSale$273KMay 13SEC ↗
MLTXSale$47KApr 16SEC ↗
MLTXSale$1.6MApr 10SEC ↗
MLTXSale$38KApr 10SEC ↗
MLTXPurchase$99KOct 9SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Bodenstedt Matthias made?

Bodenstedt Matthias has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Bodenstedt Matthias trade?

Bodenstedt Matthias has filed SEC Form 4 disclosures for 1 company, including MLTX.

When was Bodenstedt Matthias's most recent SEC Form 4 filing?

Bodenstedt Matthias's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.

What is Bodenstedt Matthias's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Bodenstedt Matthias is listed as Chief Financial Officer.

What is Bodenstedt Matthias's total buy and sell value in the current window?

Inside the rolling retention window, Bodenstedt Matthias bought $99K and sold $3.2M based on SEC Form 4 filings.

What was Bodenstedt Matthias's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 85,870 MLTX shares on 2026-04-09, worth $1.6M, per SEC Form 4 filings.